Related Experiment Videos
Drug-exposed neonates
G Hoegerman1, C A Wilson, E Thurmond
1Department of Medicine, Medical College of Virginia Hospitals, Virginia Commonwealth University, Richmond.
Insights
Drug use in pregnancy harms perinatal outcomes, causing growth issues and birth defects. It also increases risks of preterm labor and human immunodeficiency virus (HIV) infection for mothers and infants.
Area of Science:
- Obstetrics and Gynecology
- Neonatology
- Public Health
Background:
- Drug use during pregnancy poses significant risks to both mother and fetus.
- Adverse outcomes range from nonspecific effects like growth retardation to specific congenital anomalies.
- Increased rates of preterm labor and human immunodeficiency virus (HIV) transmission are critical concerns.
Purpose of the Study:
- To summarize the detrimental effects of maternal drug use on perinatal outcomes.
- To highlight specific and nonspecific consequences for fetal development and infant health.
- To underscore the rising incidence of HIV infection associated with drug abuse in pregnant populations.
Main Methods:
- Review of existing literature on drug use in pregnancy.
- Analysis of reported perinatal outcomes associated with various substances.
- Examination of epidemiological data on HIV transmission in this demographic.
Main Results:
- Maternal drug use is linked to fetal growth retardation, smaller infant size, and reduced head circumference.
- Specific effects include facial dysmorphology and organ system anomalies, exemplified by alcohol-related birth defects.
- Drug abuse elevates the risk of preterm labor and increases mother-to-infant HIV transmission rates.
Conclusions:
- Drug use during pregnancy leads to a spectrum of adverse perinatal outcomes.
- Interventions are crucial to mitigate risks of developmental anomalies, preterm birth, and infectious diseases.
- Public health strategies must address the increasing burden of HIV among drug-using pregnant individuals and their newborns.
Abstract:
Drug use during pregnancy can have detrimental effects--both nonspecific and highly specific--on the perinatal outcome. Nonspecific effects include fetal growth retardation, resulting in small infants and decreased head circumference. Specific effects include facial dysmorphology and organ system anomalies such as alcohol-related birth defects. Patients abusing drugs are at an increased risk for preterm labor, thereby placing an already compromised fetus at increased risk. The number of mothers and infants being infected by the human immunodeficiency virus from sharing needles, multiple sexual contacts, and mother-to-infant transmission is increasing at an alarming rate.